Pharma
SPARC narrows Q1 net loss to Rs 165.9 crore; income rises slightly
BullishPharma
Sun Pharma Advanced Research Company (SPARC) reported a reduced net loss of Rs 165.9 crore for the first quarter ended June 30, 2026, compared to a loss of Rs 173.4 crore year-on-year. The company's total income saw a modest increase to Rs 227.9 crore from Rs 217.6 crore in the same period last year.
Premium Signal
Subscribe to ResearchAmp Sherpa for full access to all intelligence signals, including body content, filters, and unlimited scrolling.
View Plans